iRadimed Corporation (IRMD) vs Tandem Diabetes Care, Inc. (TNDM)
- iRadimed Corporation IRMD 85.28 −0.30%
- Tandem Diabetes Care, Inc. TNDM 16.78 −6.73%
iRadimed Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.3B against $1.1B — 1.1× the size. Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 44.9×. iRadimed Corporation grew revenue faster over the last twelve months: 11.0% against 6.84%. iRadimed Corporation has the higher net margin (26.9% vs −4.58%) and the higher return on invested capital (41.8% vs −5.35%). Across the 19 metrics below, iRadimed Corporation leads on 16 and Tandem Diabetes Care, Inc. on 3.
Valuation
Profitability
| Metric | IRMD | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 75.51% | 56.65% | 57.76% |
| Operating margin | 32.30% | (2.35%) | (15.07%) |
| Net margin | 26.85% | (4.58%) | (14.45%) |
| Free cash flow margin | 28.66% | (3.37%) | (3.88%) |
| Return on equity | 23.42% | (36.74%) | (10.35%) |
| Return on assets | 20.34% | (4.84%) | (17.26%) |
| Return on invested capital | 41.79% | (5.35%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack